Champions Oncology logo
Champions Oncology CSBR
$ 6.0 -2.28%

Quarterly report 2025-Q4
added 03-12-2026

report update icon

Champions Oncology Historical Prices 2011-2026 | CSBR

Annual Historical Prices Champions Oncology

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
7.75 5.05 6.66 8.74 8.02 11 7.59 12.2 3.82 4.75 3.62 5.4 12 6.12 8.4

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
12.2 3.62 7.41

Historical Prices of other stocks in the Biotechnology industry

Issuer Historical Prices Price % 24h Market Cap Country
Amgen Amgen
AMGN
369 $ 350.13 2.98 % $ 188 B usaUSA
MorphoSys AG MorphoSys AG
MOR
18.2 - 2.43 % $ 254 M germanyGermany
Acorda Therapeutics Acorda Therapeutics
ACOR
13.5 - -24.86 % $ 820 K usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
3.86 - - $ 86.2 M usaUSA
Amneal Pharmaceuticals Amneal Pharmaceuticals
AMRX
13.8 $ 12.73 3.33 % $ 3.99 B usaUSA
AlloVir AlloVir
ALVR
9.78 - 4.14 % $ 49.1 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
0.57 - - $ 10.1 M usaUSA
argenx SE argenx SE
ARGX
691 $ 783.17 2.32 % $ 25 B niderlandNiderland
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
1.21 $ 1.48 8.82 % $ 394 M britainBritain
Applied Therapeutics Applied Therapeutics
APLT
6.42 - - $ 8.42 M usaUSA
I-Mab I-Mab
IMAB
0.68 - - $ 866 M chinaChina
Genfit SA Genfit SA
GNFT
3.36 - 2.54 % $ 160 B franceFrance
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
27.1 $ 24.57 5.59 % $ 3.13 B usaUSA
Biophytis SA Biophytis SA
BPTS
0.33 - -13.47 % $ 169 M franceFrance
AVROBIO AVROBIO
AVRO
1.27 - 1083.1 % $ 745 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
0.5 - - $ 7.46 M israelIsrael
AstraZeneca PLC AstraZeneca PLC
AZN
74.2 - - $ 96.9 B britainBritain
Midatech Pharma plc Midatech Pharma plc
MTP
0.29 - -18.52 % $ 27.3 M britainBritain
BioNTech SE BioNTech SE
BNTX
91.2 $ 91.64 2.25 % $ 27.2 B germanyGermany
BeiGene, Ltd. BeiGene, Ltd.
BGNE
185 - 0.49 % $ 251 B cayman-islandsCayman-islands
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
0.58 $ 3.82 1.6 % $ 9.19 B australiaAustralia
Burford Capital Limited Burford Capital Limited
BUR
10.6 $ 4.62 1.54 % $ 742 M britainBritain
CymaBay Therapeutics CymaBay Therapeutics
CBAY
32.3 - - $ 3.45 B usaUSA
Advaxis Advaxis
ADXS
0.31 - -9.65 % $ 45.9 M usaUSA
Aytu BioScience Aytu BioScience
AYTU
2.51 $ 2.68 4.28 % $ 16.8 M usaUSA
Avid Bioservices Avid Bioservices
CDMO
6.7 - - $ 789 M usaUSA
Cidara Therapeutics Cidara Therapeutics
CDTX
23.4 - - $ 1.41 B usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
1.45 $ 3.05 0.66 % $ 6.64 B israelIsrael
Cabaletta Bio Cabaletta Bio
CABA
2.82 $ 3.05 -0.5 % $ 306 M usaUSA
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
4.04 - - $ 169 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
5.72 - 5.93 % $ 314 M canadaCanada
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
2.44 - - $ 231 M usaUSA
Cerus Corporation Cerus Corporation
CERS
2.6 $ 1.93 4.62 % $ 368 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
13 - -10.17 % $ 12.2 K usaUSA
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
3.03 - - $ 401 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
12 - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
0.3 - - $ 26.5 M usaUSA
CTI BioPharma Corp. CTI BioPharma Corp.
CTIC
4.8 - - $ 1.2 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
3.17 - 1.93 % $ 17.4 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
3.32 - -45.71 % $ 1.2 M canadaCanada
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
4.9 - -4.36 % $ 27 M usaUSA
Cellectar Biosciences Cellectar Biosciences
CLRB
2.87 $ 2.83 2.91 % $ 7.38 M usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
14.1 - - $ 2.18 B usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
48.4 - - $ 3.67 B usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
13.3 - - $ 2.02 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
19.3 - - $ 867 M germanyGermany
Coherus BioSciences Coherus BioSciences
CHRS
1.93 $ 1.73 3.59 % $ 203 M usaUSA